← Latest Filings
S

Saxonov Serge

Chief Executive Officer

Open-market buys
0
$0 total
Open-market sells
20
$6.5M total
Tracking since
Nov 2025
Open-market sale — $231K
10x Genomics, Inc. · Sep 22, 2026
Open-market sale — $810K
10x Genomics, Inc. · Sep 22, 2026
Open-market trades from the last two years.
1,930,938 Class B Common Stock in TXG
Held indirectly (See footnote) · as of 2026-03-23
1,100,927 Class B Common Stock in TXG
Held directly · as of 2026-03-23
10x Genomics, Inc.
CIK 0001770787